What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients?
- 31 August 2008
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 71 (2) , 298-301
- https://doi.org/10.1016/j.mehy.2008.03.019
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Glucocorticoid treatment of patients with SARS: implications for mechanisms of immunopathologyNature Reviews Immunology, 2006
- Multiple organ infection and the pathogenesis of SARSThe Journal of Experimental Medicine, 2005
- Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitisClinical and Experimental Immunology, 2004
- Lymphopenia and neutrophilia in SARS are related to the prevailing serum cortisolEuropean Journal of Clinical Investigation, 2004
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- Peripheral blood lymphopenia and neutrophilia in children with severe respiratory syncytial virus diseasePediatric Pulmonology, 2002
- Th1 and Th2 subsets: paradigms lost?Immunology Today, 1995
- Endogenous cortisol: A regulator of the number of lymphocytes in peripheral bloodClinical Immunology and Immunopathology, 1980
- Morphological aspects of glucocorticoid‐induced cell death in human lymphoblastoid cellsThe Journal of Pathology, 1978
- Monocyte cellular function in asthmatic patients on alternate-day steroid therapyJournal of Allergy and Clinical Immunology, 1978